Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Infusion vs PCA for Femoral Analgesia After TKA
NCT02007850Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Change of quadriceps muscle strength at 2 days. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02007850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007850.